Keyphrases
ErbB2
100%
Ovarian Cancer
100%
Single-chain Antibody
100%
Intracellular Expression
100%
Endoplasmic Reticulum
46%
Ovarian Cancer Cells
38%
SKOV3
23%
Overexpressing
15%
Subcutaneous Tumor
15%
Primary Ovarian Cancer
15%
Anchorage-independent Growth
15%
Antineoplastic Agents
15%
Malignant Ascites
15%
Abrogation
7%
Overexpression
7%
Adenovirus
7%
Tumor Cells
7%
Neoplasms
7%
Cell Surface
7%
Biological Effects
7%
Direct Expression
7%
Growth Hormone Receptor
7%
Tumor Volume
7%
Knock
7%
Ovarian Cancer Patients
7%
In Vivo Model
7%
Tyrosine Kinase Receptor
7%
Human Ovarian Cancer Cell
7%
Intraperitoneal Injection
7%
Necropsy
7%
Tumor Formation
7%
Cytotoxic Effect
7%
Poly-L-lysine
7%
Soft Agar
7%
Plasmid DNA (pDNA)
7%
Human Ovarian Carcinoma Cells
7%
Leader Sequence
7%
Control Construct
7%
ErbB-2 Receptor
7%
Treatment Model
7%
Orthotopic Xenograft Model
7%
Transfect
7%
Tumor Eradication
7%
Subcutaneous Transplantation
7%
Immunoglobin
7%
Human Tumor Xenograft Model
7%
Animal Treatment
7%
Medicine and Dentistry
Ovarian Cancer
100%
Single Chain Fragment Variable Antibody
100%
Endoplasmic reticulum
75%
Cancer Cell
62%
Neoplasm
37%
Anchorage Independent Growth
25%
Malignant Ascites
25%
In Vitro
12%
Tumor Cell
12%
Downregulation
12%
Immunoglobulin
12%
Carcinogenesis
12%
Cell Surface
12%
Growth Factor Receptor
12%
Cell Line
12%
Knock Out
12%
Xenograft
12%
Tyrosine Kinase Receptor
12%
Cytotoxicity
12%
Adenoviridae
12%
Autopsy
12%
Ovarian Carcinoma Cell Line
12%
Tumor Xenograft
12%
Plasmid DNA
12%
Agar
12%
Polylysine
12%
Signal Peptide
12%
Biological Activity
12%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Cancer
100%
Single Chain Fragment Variable Antibody
100%
Neoplasm
62%
Malignant Ascites
25%
Carcinogenesis
12%
Immunoglobulin
12%
Growth Factor Receptor
12%
Adenoviridae
12%
Tyrosine Kinase Receptor
12%
Agar
12%
Ovary Carcinoma
12%
Polylysine
12%
Plasmid DNA
12%
Cytotoxicity
12%
Signal Peptide
12%